Keywords: novartis, exforge, cleared, eu, regulator, swiss, drug

Novartis' Exforge cleared by EU regulator

Article | 29 January 2007

Print This

Swiss drug major Novartis says that the European Commission has granted approval for Exforge (amlodipine and valsartan) as a single-pill ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in